Page 197 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Disorders of Calcium: Hypercalcemia and Hypocalcemia 187

ionized calcium concentration. Scand J Clin Lab Invest 360. Matus RE, Leifer CE, MacEwen EG, et al. Prognostic
1995;55:61–5. factors for multiple myeloma in the dog. J Am Vet Med
341. Machado CE, Flombaum CD. Safety of pamidronate in Assoc 1986;188:1288–92.
patients with renal failure and hypercalcemia. Clin 361. Matwichuk CL, Taylor SM, Daniel GB, et al. Double-
Nephrol 1996;45:175–9. phase parathyroid scintigraphy in dogs using techne-
342. MacIsaac RJ, Caple IW, Danks JA, et al. Ontogeny of tium-99m-sestamibi. Vet Radiol Ultrasound
parathyroid hormone-related protein in the ovine para- 2000;41:461–9.
thyroid gland. Endocrinology 1991;129:757–64. 362. Matwichuk CL, Taylor SM, Wilkinson AA, et al. Use of
343. MacIsaac RJ, Heath JA, Rodda CP, et al. Role of the fetal technetium Tc 99m sestamibi for detection of a parathy-
parathyroid glands and parathyroid hormone-related pro- roid adenoma in a dog with primary hyperparathyroidism.
tein in the regulation of placental transport of calcium, J Am Vet Med Assoc 1996;209:1733–6.
magnesium and inorganic phosphate. Reprod Fertil Dev 363. Mazzaferro S, Barberi S, Scarda A, et al. Ionised and total
1991;3:447–57. serum magnesium in renal transplant patients. J Nephrol
344. MacKenzie CP. Poisoning in four dogs by a compound 2002;15:275–80.
containing warfarin and calciferol. J Small Anim Pract 364. McCauley LK, Rosol TJ, Stromberg PC, et al. Effects of
1987;28:433–45. interleukin-1 alpha and cyclosporin A in vivo and
345. Maestro B, Davila N, Carranza MC, et al. Identification of in vitro on bone and lymphoid tissues in mice. Toxicol
a vitamin D response element in the human insulin recep- Pathol 1991;19:1–10.
tor gene promoter. J Steroid Biochem Mol Biol 365. McClain HM, Barsanti JA, Bartges JW. Hypercalcemia
2003;84:223–30. and calcium oxalate urolithiasis in cats: a report of five
346. Mahgoub A, Hirsch PF, Munson PL. Calcium-lowering cases. J Am Anim Hosp Assoc 1999;35:297–301.
action of glucocorticoids in adrenalectomized-parathyroi- 366. McElwain MC, Modzelewski RA, Yu WD, et al. Vitamin D:
dectomized rats: specificity and relative potency of natural an antiproliferative agent with potential for therapy of squa-
and synthetic glucocorticoids. Endocrine 1997;6:279–83. mous cell carcinoma. Am J Otolaryngol 1997;18:293–8.
347. Major P, Lortholary A, Hon J, et al. Zoledronic acid is 367. McIntyre CW. The functional cardiovascular consequences
superior to pamidronate in the treatment of hypercalce- of vascular calcification. Semin Dial 2007;20:122–8.
mia of malignancy: a pooled analysis of two randomized, 368. Mealey KL, Willard MD, Nagode LA, et al. Hypercalce-
controlled clinical trials. J Clin Oncol 2001;19:558–67. mia associated with granulomatous disease in a cat. J
348. Major P. The use of zoledronic acid, a novel, highly potent Am Vet Med Assoc 1999;215:959–62.
bisphosphonate, for the treatment of hypercalcemia of 369. Mellanby RJ, Craig R, Evans H, Herrtage ME. Plasma
malignancy. Oncologist 2002;7:481–91. concentrations of parathyroid hormone-related protein
349. Malberti F, Surian M, Cosci P. Improvement of secondary in dogs with potential disorders of calcium metabolism.
hyperparathyroidism and reduction of the set point of cal- Vet Rec 2006;159(25):833–8.
cium after intravenous calcitriol. Kidney Int Suppl 370. Mellanby RJ, Mee AP, Berry JL, Herrtage ME.
1993;41:S125–30. Hypercalcaemia in two dogs caused by excessive dietary
350. Mangin M, Ikeda K, Broadus AE. Structure of the mouse supplementation of vitamin D. J Small Anim Pract
gene encoding parathyroid hormone-related peptide. 2005;46(7):334–8.
Gene 1990;95:195–202. 371. Mellanby RJ, Mellor PJ, Roulois A, Baines EA, Mee AP,
351. Marchetti V, Lubas G, Baneth G, Modenato M, Berry JL, et al. Hypocalcaemia associated with low serum
Mancianti F. Hepatozoonosis in a dog with skeletal vitamin D metabolite concentrations in two dogs with
involvement and meningoencephalomyelitis. Vet Clin protein-losing enteropathies. J Small Anim Pract
Pathol 2009;38(1):121–5. 2005;46(7):345–51.
352. Markowitz GS, Fine PL, Stack JI, et al. Toxic acute tubular 372. Mellanby RJ, Mellor P, Villiers EJ, Herrtage ME,
necrosis following treatment with zoledronate (Zometa). Halsall D, O’Rahilly S, et al. Hypercalcemia associated
Kidney Int 2003;64:281–9. with granulomatous lymphadenitis and elevated 1,25
353. Marquez GA, Klausner JS, Osborne CA. Calcium oxalate dihydroxyvitamin D concentration in a dog. J Small Anim
urolithiasis in a cat with a functional parathyroid adenocar- Pract 2006;47(4):207–12.
cinoma. J Am Vet Med Assoc 1995;206:817–9. 373. Meller Y, Kestenbaum RS, Yagil R, et al. The influence of
354. Martin LG. Hypercalcemia and hypermagnesemia. Vet age and sex on blood levels of calcium-regulating hormones
Clin North Am Small Anim Pract 1998;28:565–85. in dogs. Clin Orthop Relat Res 1984;187:296–9.
355. Martin TJ, Grill V. Hypercalcemia in cancer. J Steroid 374. Merryman JI, Rosol TJ, Brooks CL, et al. Separation of
Biochem Mol Biol 1992;43:123–9. parathyroid hormone-like activity from transforming
356. Martin-Salvago M, Villar-Rodriguez JL, Palma-Alvarez A, growth factor-alpha and -beta in the canine adenocarci-
et al. Decreased expression of calcium receptor in parathy- noma (CAC-8) model of humoral hypercalcemia of malig-
roid tissue in patients with hyperparathyroidism nancy. Endocrinology 1989;124:2456–63.
secondary to chronic renal failure. Endocr Pathol 375. Messinger JS, Windham WR, Ward CR. Ionized hypercal-
2003;14:61–70. cemia in dogs: a retrospective study of 109 cases (1998-
357. Massry SG. Pathogenesis of uremic toxicity, Part 1. Para- 2003). J Vet Intern Med 2009;23(3):514–9.
thyroid hormone as a uremic toxin. In: Massry SG, 376. Meuten DJ, Chew DJ, Capen CC, et al. Relationship of
Glassock RJ, editors. Textbook of nephrology. Baltimore: serum total calcium to albumin and total protein in dogs.
Williams & Wilkins; 1989. p. 1126–1144. J Am Vet Med Assoc 1982;180:63–7.
358. Mathew S, Lund RJ, Chaudhary LR, et al. Vitamin D 377. Meuten DJ, Cooper BJ, Capen CC, et al. Hypercalcemia
receptor activators can protect against vascular calcifica- associated with an adenocarcinoma derived from the
tion. J Am Soc Nephrol 2008;19:1509–19. apocrine glands of the anal sac. Vet Pathol
359. Mathew S, Tustison KS, Sugatani T, et al. The mechanism 1981;18:454–71.
of phosphorus as a cardiovascular risk factor in CKD. J Am 378. Meuten DJ, Kociba GJ, Capen CC, et al. Hypercalcemia
Soc Nephrol 2008;19:1092–105. in dogs with lymphosarcoma: biochemical,